Wojcicki-Backed Treehub to Grow Health AI Startups From a Lab, Not a Garage

PALO ALTO, CA – April 22, 2026 – A new venture backed by some of Silicon Valley's most influential figures has launched with the ambitious goal of transforming how medical breakthroughs move from the laboratory to the patient. Treehub, a Stanford-adjacent residency program, officially opened its doors today, aiming to scout and nurture the next generation of healthcare founders from within the halls of academia and science.

Supported by its dedicated venture arm, the AI Health Fund, Treehub is positioning itself as a critical bridge over the infamous “valley of death” in innovation—the treacherous gap between a brilliant scientific idea and a viable, fundable company. The program is led by a team that includes Stanford faculty and is advised by luminaries such as educator Esther Wojcicki and 23andMe founder Anne Wojcicki, signaling a serious effort to merge academic rigor with entrepreneurial velocity.

Bridging the 'Valley of Death' in Healthcare

For decades, a persistent challenge has plagued the healthcare industry: countless promising discoveries made in university labs never reach the public. These innovations often perish not for lack of scientific merit, but due to a lack of early-stage capital, business mentorship, and a clear path to market. Scientist-founders, while experts in their fields, are often unequipped to navigate the complex worlds of venture capital, regulatory approval, and company formation.

Treehub was created to solve this specific problem. “The next great healthcare company probably isn't being built in a garage. It's being built in a lab by a scientist who has never had a venture partner willing to back them at the earliest stage. Treehub bridges that gap,” said Mary Minno, Founding Partner of Treehub. “These founders deserve a dedicated path built around them, not bolted onto a traditional fund structure.”

The industry is littered with challenges that stall innovation. Integrating new AI tools with legacy hospital systems, ensuring data quality and privacy, and navigating the complex FDA approval process are significant hurdles. By intervening at the pre-formation stage, Treehub aims to equip founders with the resources and strategic guidance needed to overcome these obstacles from day one.

“What we are funding out of academic circles will actually move the needle on patient outcomes and help solve today’s broken healthcare ecosystem,” Minno added, emphasizing the program's focus on tangible, real-world impact.

A New Model: Venture Studio Meets Academic Residency

Treehub is not a typical accelerator or incubator. Instead, it combines the hands-on support of a venture studio, the community of an incubator, and the financial power of a dedicated venture fund. Its most significant differentiator is its commitment to providing capital before a company is even officially formed. The AI Health Fund writes the first check into every Treehub company, a crucial lifeline that allows founders to focus on development without the immediate pressure of fundraising.

Located in Los Altos, just off the Stanford campus, the program will run intimate cohorts of up to 10 companies four times per year. This “boutique residency” model ensures each founding team receives intensive, personalized support. Beyond capital, participants gain access to a suite of resources rarely available to early-stage startups, including proprietary medical data, curated programming with industry buyers and investors, and direct mentorship from founders who have successfully built and sold multiple companies.

While other programs exist to support university spinouts, Treehub’s combination of pre-seed capital, deep academic integration, and an elite operational network represents a unique and concentrated effort to de-risk and accelerate deep-tech healthcare ventures at their most fragile stage.

Silicon Valley Power and Stanford's Ecosystem

The team behind Treehub represents a formidable convergence of expertise. Leadership includes Minno, a former venture-backed founder and Google product executive; Dr. Roxana Daneshjou and Dr. Alexander Ioannidis, both Assistant Professors at Stanford; and Derek Minno, President of Point Capital. However, it is the involvement of the Wojcicki family that lends the venture its distinct Silicon Valley pedigree.

Esther Wojcicki, an acclaimed educator known as the “Godmother of Silicon Valley,” serves as Founding Advisor. She brings her celebrated “TRICK” philosophy—Trust, Respect, Independence, Collaboration, and Kindness—to the program's core. “TRICK are just as essential in building transformative companies as they are in raising successful individuals,” Wojcicki stated. “Treehub embodies these values, bringing together the academic rigor, moral clarity, and collaborative spirit to back the founders who will transform how we care for one another.”

Her daughter, Anne Wojcicki, founder and CEO of the pioneering consumer genetics company 23andMe, joins as an Operating Partner. Her experience scaling a complex, science-driven company from an idea to a household name provides invaluable, real-world perspective for the scientist-founders Treehub aims to support. “I’ve seen what happens when brilliant scientists get the right support at the right moment,” said Anne Wojcicki. “Treehub is building the infrastructure to make that repeatable and at the scale and speed the healthcare industry actually needs.”

Targeting the Future of AI-Driven Medicine

Treehub is built on the conviction that the most profound healthcare transformations will emerge from the intersection of biology, genomics, and artificial intelligence. The fund has sharpened its focus on three key investment domains where this convergence is already reshaping the possibilities of medicine.

First is Precision Outcomes, which aims to move beyond one-size-fits-all treatments. This includes everything from genomic risk stratification, which uses a person’s genetic makeup to predict disease, to consumer-driven care models that empower patients with personalized health data.

Second, the program will target Care Efficiency. This domain focuses on using AI to tackle the immense administrative burden plaguing healthcare. Innovations like ambient intelligence—which can automatically document doctor-patient conversations—and automated logistics are key to reducing burnout and returning focus to patient care.

Finally, Treehub is investing in Frontier Science. This category encompasses the most futuristic and potentially disruptive technologies, from AI-assisted robotic surgery and advanced medical imaging to the creation of digital twin simulations for testing new drugs and procedures. These are the cornerstone technologies expected to define the future of human health.

The inaugural cohort is scheduled to launch during Stanford's Spring Quarter of 2026, marking the first step in a long-term mission to systematically cultivate groundbreaking ideas into companies that can deliver a healthier future.